Using electronic cigarettes after quitting traditional smoking may reduce the health benefits of smoking cessation, potentially increasing the risk of lung cancer and mortality, according to a recent analysis published in Nature Medicine. Research led by Dr. Mahdi Sheikh of the International Agency for Research on Cancer (IARC) and Dr. Pamela M. Ling of the University of California San Francisco evaluated data from 4.5 million former smokers, suggesting that vaping may not be a benign substitute for combustible tobacco.
How does e-cigarette use affect post-cessation lung cancer risk?
Current evidence suggests that transitioning from combustible cigarettes to e-cigarettes does not fully eliminate the risk of lung cancer. A study by Kim et al., which analyzed the health outcomes of 4.5 million “ever-smokers” in the Republic of Korea, classified participants into groups of current smokers, quitters who transitioned to vaping, and quitters who abstained from all nicotine products. The findings indicate that those who used e-cigarettes after quitting traditional smoking faced higher rates of lung cancer and mortality compared to those who quit nicotine use entirely, according to the IARC commentary.
The study by Kim et al. is one of the largest to date, tracking millions of individuals to isolate the specific impact of e-cigarette use as a secondary habit after smoking cessation.
Why do experts call for more research on long-term vaping?
While the initial data points toward increased risks, researchers emphasize that significant knowledge gaps remain. Dr. Sheikh and Dr. Ling note that evaluating the long-term health trajectory of former smokers requires more granular data regarding the types of devices used, the duration of use, and the specific chemical composition of the e-liquids involved. The Nature Medicine article serves as a companion piece to the Kim et al. study, intended to provide context on the limitations of current observational data and the urgent need for longitudinal studies that track health outcomes over several decades.
What are the limitations of current e-cigarette studies?
Attributing specific cancer risks to e-cigarettes is complicated by the “healthy user bias” and the difficulty of isolating vaping from previous smoking histories. Dr. Sheikh highlights that many participants in these studies are long-term former smokers, making it challenging to determine if a lung cancer diagnosis is a result of decades of traditional cigarette use or the ongoing use of e-cigarettes. Future research must better account for these confounding factors to provide clearer public health guidance, according to the IARC analysis.
If you are looking to quit smoking, consult with a healthcare provider about evidence-based cessation methods—such as FDA-approved nicotine replacement therapies—which have a more established safety profile than e-cigarettes.
Frequently Asked Questions
- Does switching to vaping eliminate lung cancer risk?
No. According to the research by Kim et al., e-cigarette use after quitting traditional smoking may attenuate, or weaken, the protective benefits of smoking cessation. - Is vaping considered a safe alternative for former smokers?
The Nature Medicine commentary suggests that the long-term health effects of e-cigarettes are not yet fully understood and may still contribute to cancer risk and mortality. - Where can I read the original research?
The study by Kim et al. and the accompanying Nature Medicine article by Sheikh and Ling are available via their respective DOIs: 10.1038/s41591-026-04469-5 and 10.1038/s41591-026-04470-y.
Are you interested in the latest developments in tobacco control and cancer prevention? Subscribe to our newsletter for weekly updates on clinical research and public health news.
Worth a look